Momentum investors rely on a combination of astute analysis and timing to maximize gains. While this approach can carry a fair degree of risk, the allure of identifying a fast-growing stock and joining a rally that has room to continue is powerful.
The strong potential for explosive growth that characterizes the biopharmaceuticals industry makes it a primary target for many momentum investors, and two companies in that space have recently achieved significant gains. The first, uniQure N.V. (NASDAQ: QURE), saw a major share price leap in late September and has worked to continue those gains in the following month. The other, Omeros Corp. (NASDAQ: OMER), experienced a jump in price in mid-October.
